This report contains market size and forecasts of Anti-obesity Drugs in global, including the following market information:
Global Anti-obesity Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Anti-obesity Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Anti-obesity Drugs companies in 2020 (%)
The global Anti-obesity Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-obesity Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-obesity Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, By Type, 2020 (%)
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, By Application, 2020 (%)
Kids
Adults
Global Anti-obesity Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-obesity Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-obesity Drugs revenues share in global market, 2020 (%)
Key companies Anti-obesity Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Anti-obesity Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Anti-obesity Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-obesity Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-obesity Drugs Overall Market Size
2.1 Global Anti-obesity Drugs Market Size: 2021 VS 2027
2.2 Global Anti-obesity Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anti-obesity Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Anti-obesity Drugs Players in Global Market
3.2 Top Global Anti-obesity Drugs Companies Ranked by Revenue
3.3 Global Anti-obesity Drugs Revenue by Companies
3.4 Global Anti-obesity Drugs Sales by Companies
3.5 Global Anti-obesity Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-obesity Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anti-obesity Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-obesity Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-obesity Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-obesity Drugs Market Size Markets, 2021 & 2027
4.1.2 Peripherally Acting Anti-obesity Drugs
4.1.3 Centrally Acting Anti-obesity Drugs
4.2 By Type - Global Anti-obesity Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-obesity Drugs Revenue, 2016-2021
4.2.2 By Type - Global Anti-obesity Drugs Revenue, 2022-2027
4.2.3 By Type - Global Anti-obesity Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Anti-obesity Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-obesity Drugs Sales, 2016-2021
4.3.2 By Type - Global Anti-obesity Drugs Sales, 2022-2027
4.3.3 By Type - Global Anti-obesity Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-obesity Drugs Market Size, 2021 & 2027
5.1.2 Kids
5.1.3 Adults
5.2 By Application - Global Anti-obesity Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-obesity Drugs Revenue, 2016-2021
5.2.2 By Application - Global Anti-obesity Drugs Revenue, 2022-2027
5.2.3 By Application - Global Anti-obesity Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Anti-obesity Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-obesity Drugs Sales, 2016-2021
5.3.2 By Application - Global Anti-obesity Drugs Sales, 2022-2027
5.3.3 By Application - Global Anti-obesity Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Anti-obesity Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Anti-obesity Drugs Market Size, 2021 & 2027
6.2 By Region - Global Anti-obesity Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-obesity Drugs Revenue, 2016-2021
6.2.2 By Region - Global Anti-obesity Drugs Revenue, 2022-2027
6.2.3 By Region - Global Anti-obesity Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Anti-obesity Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-obesity Drugs Sales, 2016-2021
6.3.2 By Region - Global Anti-obesity Drugs Sales, 2022-2027
6.3.3 By Region - Global Anti-obesity Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Anti-obesity Drugs Revenue, 2016-2027
6.4.2 By Country - North America Anti-obesity Drugs Sales, 2016-2027
6.4.3 US Anti-obesity Drugs Market Size, 2016-2027
6.4.4 Canada Anti-obesity Drugs Market Size, 2016-2027
6.4.5 Mexico Anti-obesity Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Anti-obesity Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Anti-obesity Drugs Sales, 2016-2027
6.5.3 Germany Anti-obesity Drugs Market Size, 2016-2027
6.5.4 France Anti-obesity Drugs Market Size, 2016-2027
6.5.5 U.K. Anti-obesity Drugs Market Size, 2016-2027
6.5.6 Italy Anti-obesity Drugs Market Size, 2016-2027
6.5.7 Russia Anti-obesity Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Anti-obesity Drugs Market Size, 2016-2027
6.5.9 Benelux Anti-obesity Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Anti-obesity Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Anti-obesity Drugs Sales, 2016-2027
6.6.3 China Anti-obesity Drugs Market Size, 2016-2027
6.6.4 Japan Anti-obesity Drugs Market Size, 2016-2027
6.6.5 South Korea Anti-obesity Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Anti-obesity Drugs Market Size, 2016-2027
6.6.7 India Anti-obesity Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Anti-obesity Drugs Revenue, 2016-2027
6.7.2 By Country - South America Anti-obesity Drugs Sales, 2016-2027
6.7.3 Brazil Anti-obesity Drugs Market Size, 2016-2027
6.7.4 Argentina Anti-obesity Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-obesity Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Anti-obesity Drugs Sales, 2016-2027
6.8.3 Turkey Anti-obesity Drugs Market Size, 2016-2027
6.8.4 Israel Anti-obesity Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Anti-obesity Drugs Market Size, 2016-2027
6.8.6 UAE Anti-obesity Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Anti-obesity Drugs Major Product Offerings
7.1.4 Merck Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Merck Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Anti-obesity Drugs Major Product Offerings
7.2.4 Novo Nordisk Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Novo Nordisk Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Anti-obesity Drugs Major Product Offerings
7.3.4 Pfizer Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Corporate Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Anti-obesity Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Arena Pharmaceuticals Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Anti-obesity Drugs Major Product Offerings
7.5.4 Roche Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Roche Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-obesity Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline Key News
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Corporate Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-obesity Drugs Major Product Offerings
7.4.4 Orexigen Therapeutics Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Orexigen Therapeutics Key News
7.8 Vivus
7.8.1 Vivus Corporate Summary
7.8.2 Vivus Business Overview
7.8.3 Vivus Anti-obesity Drugs Major Product Offerings
7.8.4 Vivus Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Vivus Key News
7.9 Amylin
7.9.1 Amylin Corporate Summary
7.9.2 Amylin Business Overview
7.9.3 Amylin Anti-obesity Drugs Major Product Offerings
7.9.4 Amylin Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Amylin Key News
7.10 Alizyme
7.10.1 Alizyme Corporate Summary
7.10.2 Alizyme Business Overview
7.10.3 Alizyme Anti-obesity Drugs Major Product Offerings
7.10.4 Alizyme Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Alizyme Key News
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Corporate Summary
7.11.2 Boehringer Ingelheim Anti-obesity Drugs Business Overview
7.11.3 Boehringer Ingelheim Anti-obesity Drugs Major Product Offerings
7.11.4 Boehringer Ingelheim Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Boehringer Ingelheim Key News
7.12 Eisai
7.12.1 Eisai Corporate Summary
7.12.2 Eisai Anti-obesity Drugs Business Overview
7.12.3 Eisai Anti-obesity Drugs Major Product Offerings
7.12.4 Eisai Anti-obesity Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Eisai Key News
8 Global Anti-obesity Drugs Production Capacity, Analysis
8.1 Global Anti-obesity Drugs Production Capacity, 2016-2027
8.2 Anti-obesity Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-obesity Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-obesity Drugs Supply Chain Analysis
10.1 Anti-obesity Drugs Industry Value Chain
10.2 Anti-obesity Drugs Upstream Market
10.3 Anti-obesity Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-obesity Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Anti-obesity Drugs in Global Market
Table 2. Top Anti-obesity Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anti-obesity Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anti-obesity Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Anti-obesity Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Anti-obesity Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anti-obesity Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Anti-obesity Drugs Product Type
Table 9. List of Global Tier 1 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-obesity Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type